Application of the World Health Organization Reporting System for Lung Cytopathology: Risk of Malignancy and Overall Survival in Fine-Needle Aspiration Biopsies
Acta Cytologica · 28.05.2026 · 1-11
DOI: 10.1159/000552703 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Cytologica, online erschienen am 28.05.2026. Verfasst von Awab Abdalhai und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
Introduction
The World Health Organization (WHO) Reporting System for lung cytopathology provides a 5-tiered diagnostic framework. However, validation of the associated risk of malignancy (ROM) and clinical outcomes remains limited. This study evaluated the performance of the WHO reporting system by assessing ROM and overall survival (OS) in lung fine-needle aspiration biopsies (FNAB) specimens.
Methods
A retrospective review of the institutional pathology database identified patients who underwent endobronchial ultrasound-guided transbronchial FNAB or transthoracic CT-guided FNAB for lung lesions between January 2015 and June 2022. All cases were recategorized according to the WHO reporting system. Absolute ROM was determined by histologic and/or clinical follow-up of at least 6 months and compared with published studies that used the WHO and other international reporting systems. OS rates were analyzed across diagnostic categories.
Results
A total of 1,038 FNAB cases were included. The ROM for each WHO diagnostic category was as follows: insufficient/inadequate/nondiagnostic, 19%; benign, 9%; atypical, 33%; suspicious for malignancy, 84%; and malignant, 100%. These findings demonstrated overall concordance with prior studies, with comparatively lower ROMs in the insufficient/inadequate/nondiagnostic, benign, and atypical categories, and upper range ROMs in the suspicious for malignancy and malignant categories. Immunocytochemistry and molecular testing performed on available cell block materials supported tumor subtyping and therapeutic decision-making.
Conclusions
Application of the WHO reporting system significantly improves stratification of ROM and OS across diagnostic categories in lung FNAB specimens. Inclusion of a benign category and reclassification of low-grade carcinomas as malignant enhance diagnostic precision and support optimized patient management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
- Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA, qun.wang@emory.edu.
Zitieren
APA
Abdalhai, A., Hsiao, W. Y., & Wang, Q. (2026). Application of the World Health Organization Reporting System for Lung Cytopathology: Risk of Malignancy and Overall Survival in Fine-Needle Aspiration Biopsies. Acta Cytologica, 1-11. https://doi.org/10.1159/000552703
Vancouver
Abdalhai A, Hsiao WY, Wang Q. Application of the World Health Organization Reporting System for Lung Cytopathology: Risk of Malignancy and Overall Survival in Fine-Needle Aspiration Biopsies. Acta Cytologica. 2026:1-11. doi:10.1159/000552703
BibTeX
@article{Abdalhai2026,
author = {Abdalhai, Awab and Hsiao, Wen-Yu and Wang, Qun},
title = {Application of the World Health Organization Reporting System for Lung Cytopathology: Risk of Malignancy and Overall Survival in Fine-Needle Aspiration Biopsies},
journal = {Acta Cytologica},
year = {2026},
pages = {1--11},
doi = {10.1159/000552703}
}
EUVIMED